Oxford Brain Diagnostics
Generated by Meeveem AI
"Analysing brain cellular structure to advance dementia diagnosis and drug development"
Oxford
•11 - 50 Employees
•Digital Health
About Oxford Brain Diagnostics
Oxford Brain Diagnostics develops advanced MRI analysis technology that assesses brain health by examining cellular level changes. The company's patented Cortical Disarray Measurement technology enables early detection, progression tracking, and differentiation of neurodegenerative diseases such as Alzheimer's and Parkinson's, unlocking insights previously only accessible post mortem. The technology serves pharmaceutical companies seeking reliable biomarkers for clinical trials, and clinicians diagnosing and monitoring patients with neurodegenerative conditions. With FDA clearance and UKCA approval, Oxford Brain Diagnostics provides software products and analytical services advancing dementia treatment and drug development.
20
Team Members
2019
Founded
Digital Health
Sector
On-Site
Work Environment
Our Vision
A world where brain health is understood at the cellular level, enabling early intervention and personalised care that prevents or slows neurodegenerative diseases before symptoms emerge.
Our Mission
At Oxford Brain Diagnostics, our mission is to analyse the cellular structure of the brain in a way no one else can, to support drug development and aid clinicians in their fight to defeat Alzheimer's and other neurodegenerative conditions.